Can pharmacogenomics improve malaria drug policy?

Simple item page
dc.coverageGeneva
dc.creatorRoederer, Mary W
dc.creatorMcLeod, Howard
dc.creatorJuliano, Jonathan J
dc.date2018-03-26T03:08:12Z
dc.date2018-03-26T03:08:12Z
dc.date2011-11-01
dc.date2011-09-01
dc.date.accessioned2026-08-03T07:43:21Z
dc.description838
dc.description845
dc.formatapplication/pdf
dc.identifier0042-9686
dc.identifierhttps://iris.who.int/handle/10665/270991
dc.identifier10.2471/BLT.11.087320
dc.identifierPMC3209725
dc.identifier22084530
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/218247
dc.languageEnglish
dc.languageen
dc.publisherWorld Health Organization
dc.relationBulletin of the World Health Organization
dc.relation11
dc.relation89
dc.subjectPolicy and Practice
dc.titleCan pharmacogenomics improve malaria drug policy?
dc.typeJournal articles

Files

Collections

WHO IRIS